ABIO logo

ARCA Biopharma (ABIO) Current Liabilities

Annual Current Liabilities

$637.00 K
-$495.00 K-43.73%

December 31, 2023

Summary

Performance

1-Year Change

-43.73%

3-Year Change

-81.79%

5-Year Change

-19.67%

15-Year Change

-69.23%

ABIO Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$43.84 M
ABIO annual total current liabilities is currently -98.55% below its historical high of $43.84 million

3-Year Low

$637.00 K
ABIO annual total current liabilities is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
ABIO previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
ABIO next annual earnings announcement has not yet been scheduled

OtherABIObalance sheetmetrics:

Annual Total Liabilities

$841.00 K
ABIO annual total liabilities is $841.00 thousand

Annual Total Long Term Liabilities

$204.00 K
ABIO annual total long term liabilities is $204.00 thousand

Annual Total Assets

$37.86 M
ABIO annual total assets is $37.86 million

Annual Current Assets

$37.43 M
ABIO annual total current assets is $37.43 million

Quarterly Current Liabilities

$1.27 M
-$310.00 K-19.61%

June 30, 2024

Summary

Performance

3-Month Change

-19.61%

1-Year Change

+99.53%

3-Year Change

-60.06%

5-Year Change

-60.06%

ABIO Quarterly Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$43.84 M
ABIO quarterly total current liabilities is currently -97.10% below its historical high of $43.84 million

3-Year Low

$637.00 K
ABIO quarterly total current liabilities is currently +99.53% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2024
ABIO previous earnings announcement was published on Jun 30, 2024

Next Quarterly Earnings Report Date

N/A
ABIO next earnings announcement has not yet been scheduled

OtherABIObalance sheetmetrics:

Quarterly Total Liabilities

$1.27 M
ABIO quarterly total liabilities is $1.27 million

Quarterly Long Term Liabilities

$0.00
ABIO quarterly total long term liabilities is $0.00

Quarterly Total Assets

$33.84 M
ABIO quarterly total assets is $33.84 million

Quarterly Current Assets

$33.82 M
ABIO quarterly total current assets is $33.82 million

Current Liabilities Formula

Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities

Annual Current Liabilities

$637.00 K
ABIO annual total current liabilities is $637.00 thousand

Annual Accounts Payable

$362.00 K
ABIO annual accounts payable is $362.00 thousand

Annual Short Term Debt

-
ABIO annual short term debt value is unknown

ABIO Current Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-43.7%+99.5%
3 y3 years-81.8%-60.1%
5 y5 years-19.7%-60.1%

ABIO Current Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-81.8%at low-63.7%-49.9%
5 y5-year-81.8%at low-65.6%-49.9%
alltimeall time-98.5%-52.1%-97.1%-77.5%

ARCA Biopharma Current Liabilities History

DateAnnualQuarterly
Jun 2024
-
$1.27 M(-19.6%)
Mar 2024
-
$1.58 M(+148.2%)
Dec 2023
$637.00 K(-43.7%)
$637.00 K(-35.8%)
Sep 2023
-
$992.00 K(-38.1%)
Jun 2023
-
$1.60 M(+26.5%)
Mar 2023
-
$1.27 M(+11.8%)
Dec 2022
$1.13 M(-67.6%)
$1.13 M(-41.6%)
Sep 2022
-
$1.94 M(-31.0%)
Jun 2022
-
$2.81 M(+3.3%)
Mar 2022
-
$2.72 M(-22.3%)
Dec 2021
$3.50 M(-0.0%)
$3.50 M(+9.9%)
Sep 2021
-
$3.18 M(-13.9%)
Jun 2021
-
$3.69 M(+28.3%)
Mar 2021
-
$2.88 M(-17.7%)
Dec 2020
$3.50 M(+277.9%)
$3.50 M(+129.1%)
Sep 2020
-
$1.53 M(+15.0%)
Jun 2020
-
$1.33 M(+15.0%)
Mar 2020
-
$1.16 M(+24.7%)
Dec 2019
$926.00 K(+16.8%)
$926.00 K(-19.5%)
Sep 2019
-
$1.15 M(-4.1%)
Jun 2019
-
$1.20 M(-6.9%)
Mar 2019
-
$1.29 M(+62.4%)
Dec 2018
$793.00 K(-61.7%)
$793.00 K(-18.9%)
Sep 2018
-
$978.00 K(-7.7%)
Jun 2018
-
$1.06 M(-38.3%)
Mar 2018
-
$1.72 M(-17.0%)
Dec 2017
$2.07 M(-13.6%)
$2.07 M(-18.6%)
Sep 2017
-
$2.54 M(+1.0%)
Jun 2017
-
$2.52 M(+0.0%)
Mar 2017
-
$2.52 M(+5.1%)
Dec 2016
$2.40 M(+59.3%)
$2.40 M(+11.1%)
Sep 2016
-
$2.16 M(+27.0%)
Jun 2016
-
$1.70 M(-27.6%)
Mar 2016
-
$2.34 M(+55.9%)
Dec 2015
$1.50 M(+8.4%)
$1.50 M(+15.3%)
Sep 2015
-
$1.30 M(-3.8%)
Jun 2015
-
$1.36 M(+19.7%)
Mar 2015
-
$1.13 M(-18.4%)
Dec 2014
$1.39 M(-7.6%)
$1.39 M(+65.6%)
Sep 2014
-
$838.00 K(-31.1%)
Jun 2014
-
$1.22 M(+8.7%)
Mar 2014
-
$1.12 M(-25.4%)
Dec 2013
$1.50 M(+392.5%)
$1.50 M(+95.3%)
Sep 2013
-
$769.00 K(+2.5%)
Jun 2013
-
$750.00 K(-9.4%)
Mar 2013
-
$828.00 K(+171.5%)
Dec 2012
$305.00 K(-59.5%)
$305.00 K(+6.6%)
Sep 2012
-
$286.00 K(-45.9%)
Jun 2012
-
$529.00 K(-10.9%)
Mar 2012
-
$594.00 K(-21.2%)
Dec 2011
$754.00 K(-36.6%)
$754.00 K(+14.1%)
Sep 2011
-
$661.00 K(-34.2%)
Jun 2011
-
$1.00 M(-34.7%)
Mar 2011
-
$1.54 M(+29.2%)
Dec 2010
$1.19 M
$1.19 M(+47.8%)
DateAnnualQuarterly
Sep 2010
-
$805.00 K(-17.5%)
Jun 2010
-
$976.00 K(-9.7%)
Mar 2010
-
$1.08 M(-34.2%)
Dec 2009
$1.64 M(-89.6%)
$1.64 M(-33.4%)
Sep 2009
-
$2.47 M(-87.2%)
Jun 2009
-
$19.25 M(+30.3%)
Mar 2009
-
$14.77 M(-6.7%)
Dec 2008
$15.83 M(-13.0%)
$15.83 M(+10.4%)
Sep 2008
-
$14.35 M(-13.2%)
Jun 2008
-
$16.53 M(-48.6%)
Mar 2008
-
$32.19 M(+77.0%)
Dec 2007
$18.19 M(-58.5%)
$18.19 M(-15.0%)
Sep 2007
-
$21.41 M(-22.4%)
Jun 2007
-
$27.58 M(-19.0%)
Mar 2007
-
$34.04 M(-22.4%)
Dec 2006
$43.84 M(+21.2%)
$43.84 M(+18.6%)
Sep 2006
-
$36.97 M(-7.8%)
Jun 2006
-
$40.08 M(-3.4%)
Mar 2006
-
$41.48 M(+14.7%)
Dec 2005
$36.18 M(+60.0%)
$36.18 M(-7.9%)
Sep 2005
-
$39.30 M(+29.3%)
Jun 2005
-
$30.40 M(+30.8%)
Mar 2005
-
$23.24 M(+2.8%)
Dec 2004
$22.61 M(+60.5%)
$22.61 M(-29.2%)
Sep 2004
-
$31.94 M(+15.9%)
Jun 2004
-
$27.55 M(+3.2%)
Mar 2004
-
$26.70 M(+89.5%)
Dec 2003
$14.09 M(-47.1%)
$14.09 M(-54.3%)
Sep 2003
-
$30.84 M(+22.6%)
Jun 2003
-
$25.16 M(-21.1%)
Mar 2003
-
$31.89 M(+19.8%)
Dec 2002
$26.61 M(+47.7%)
$26.61 M(+75.5%)
Sep 2002
-
$15.16 M(-16.1%)
Jun 2002
-
$18.07 M(-7.9%)
Mar 2002
-
$19.63 M(+8.9%)
Dec 2001
$18.02 M(+119.6%)
$18.02 M(+47.3%)
Sep 2001
-
$12.23 M(+7.0%)
Jun 2001
-
$11.43 M(+19.6%)
Mar 2001
-
$9.56 M(+16.5%)
Dec 2000
$8.20 M(-24.7%)
$8.20 M(-27.4%)
Sep 2000
-
$11.30 M(-20.3%)
Jun 2000
-
$14.17 M(-11.2%)
Mar 2000
-
$15.96 M(+46.4%)
Dec 1999
$10.90 M(+84.7%)
$10.90 M(+91.2%)
Sep 1999
-
$5.70 M(+32.6%)
Jun 1999
-
$4.30 M(-21.8%)
Mar 1999
-
$5.50 M(-6.8%)
Dec 1998
$5.90 M(+73.5%)
$5.90 M(+68.6%)
Sep 1998
-
$3.50 M(-7.9%)
Jun 1998
-
$3.80 M(+11.8%)
Mar 1998
-
$3.40 M(0.0%)
Dec 1997
$3.40 M(+183.3%)
$3.40 M(-15.0%)
Sep 1997
-
$4.00 M(+48.1%)
Jun 1997
-
$2.70 M(+107.7%)
Mar 1997
-
$1.30 M
Dec 1996
$1.20 M
-

FAQ

  • What is ARCA biopharma annual total current liabilities?
  • What is the all time high annual current liabilities for ARCA biopharma?
  • What is ARCA biopharma annual current liabilities year-on-year change?
  • What is ARCA biopharma quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for ARCA biopharma?
  • What is ARCA biopharma quarterly current liabilities year-on-year change?

What is ARCA biopharma annual total current liabilities?

The current annual current liabilities of ABIO is $637.00 K

What is the all time high annual current liabilities for ARCA biopharma?

ARCA biopharma all-time high annual total current liabilities is $43.84 M

What is ARCA biopharma annual current liabilities year-on-year change?

Over the past year, ABIO annual total current liabilities has changed by -$495.00 K (-43.73%)

What is ARCA biopharma quarterly total current liabilities?

The current quarterly current liabilities of ABIO is $1.27 M

What is the all time high quarterly current liabilities for ARCA biopharma?

ARCA biopharma all-time high quarterly total current liabilities is $43.84 M

What is ARCA biopharma quarterly current liabilities year-on-year change?

Over the past year, ABIO quarterly total current liabilities has changed by +$634.00 K (+99.53%)